Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication.

Suppr

超能文献

作者信息

Slater M J, Baxter R, Bonser R W, Cockerill S, Gohil K, Parry N, Robinson E, Randall R, Yeates C, Snowden W, Walters A

机构信息

GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, SG1 2NY, Stevenage, UK.

出版信息

Bioorg Med Chem Lett. 2001 Aug 6;11(15):1993-5. doi: 10.1016/s0960-894x(01)00352-3.

DOI:10.1016/s0960-894x(01)00352-3

PMID:11454465

Abstract

The synthesis and antiviral evaluation of unsymmetrical indolocarbazole derivatives of Arcyriaflavin A, substituted with a range of alkyl groups at the indole nitrogen, is described. Structure-activity relationships in this series against human cytomegalovirus (HCMV) replication in cell culture are reported. Compound 4b was identified as potent inhibitor of HCMV (IC(50)=19 nM), which retained activity against a range of HCMV strains including ganciclovir resistant isolates.

摘要

相似文献

Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication.

Bioorg Med Chem Lett. 2001 Aug 6;11(15):1993-5. doi: 10.1016/s0960-894x(01)00352-3.

Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication.吲哚咔唑：人类巨细胞病毒复制的强效、选择性抑制剂。

Bioorg Med Chem. 1999 Jun;7(6):1067-74. doi: 10.1016/s0968-0896(99)00032-2.

Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase.吲哚咔唑对人巨细胞病毒具有强大的抗病毒活性，并且是pUL97蛋白激酶的有效抑制剂。

Antiviral Res. 2000 Oct;48(1):49-60. doi: 10.1016/s0166-3542(00)00118-2.

Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97.人巨细胞病毒复制抑制剂可大幅降低病毒蛋白激酶pUL97的活性。

J Gen Virol. 2001 Jun;82(Pt 6):1439-1450. doi: 10.1099/0022-1317-82-6-1439.

Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.具有强大抗巨细胞病毒活性的新型pUL97蛋白激酶特异性抑制剂化学类别。

Antimicrob Agents Chemother. 2004 Nov;48(11):4154-62. doi: 10.1128/AAC.48.11.4154-4162.2004.

Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy.激酶抑制剂直接靶向人巨细胞病毒蛋白激酶pUL97是抗病毒治疗的新原理。

J Gen Virol. 2002 May;83(Pt 5):1013-1023. doi: 10.1099/0022-1317-83-5-1013.

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.1263W94（一种具有独特作用模式的苯并咪唑L-核糖苷）对人巨细胞病毒复制具有强效且选择性的抑制作用。

Antimicrob Agents Chemother. 2002 Aug;46(8):2365-72. doi: 10.1128/AAC.46.8.2365-2372.2002.

The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.青蒿琥酯是一种有效的人巨细胞病毒复制抑制剂。

Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00288-18. Print 2018 Jul.

Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir.人巨细胞病毒临床分离株对BAY38 - 4766、BAY43 - 9695和更昔洛韦的敏感性。

Antimicrob Agents Chemother. 2001 Oct;45(10):2925-7. doi: 10.1128/AAC.45.10.2925-2927.2001.

Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cells.更昔洛韦和青蒿琥酯对星形胶质细胞瘤细胞中人巨细胞病毒的抗病毒活性。

Antiviral Res. 2011 Feb;89(2):186-8. doi: 10.1016/j.antiviral.2010.12.002. Epub 2010 Dec 15.

引用本文的文献

The Cytomegalovirus Protein Kinase pUL97:Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting.巨细胞病毒蛋白激酶pUL97：宿主相互作用、调控机制及抗病毒药物靶向作用

Microorganisms. 2020 Apr 4;8(4):515. doi: 10.3390/microorganisms8040515.

Marine Natural Products as Models to Circumvent Multidrug Resistance.海洋天然产物作为克服多药耐药性的模型。

Molecules. 2016 Jul 8;21(7):892. doi: 10.3390/molecules21070892.

The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.抗病毒药物研发的下十个故事（E 部分）：新进展、新进展和新冒险。

Med Res Rev. 2011 Jan;31(1):118-60. doi: 10.1002/med.20179.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验